Seiichiro Mitani

9PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 29, 2026
A prospective observational study of treatment sequencing with regorafenib and FTD/TPI in metastatic colorectal cancer: The OSERO study.

|Aug 27, 2026
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G.

|Jul 07, 2026
Intratumoral heterogeneity of intermediate CLDN18.2 expression in gastric cancer.

|May 08, 2025
A multicenter, prospective, observational study of nivolumab readministration for advanced gastric cancer (NIVO RETURNS).

Hiroyuki Kodama, Yukiya Narita, Michio Nakamura

|Aug 11, 2022
Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2-Positive Esophagogastric and Gastric Cancer.

Kaori Hino, Tomohiro Nishina, Takeshi Kajiwara

|May 13, 2022
Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502.

Seiichiro Mitani, Ken Kato, Hiroyuki Daiko

Pageof 2

Frequent Collaborators

3 joint publications

Takayuki Ando

2 joint publications

Shigenori Kadowaki

2 joint publications

Hideaki Bando

2 joint publications

Hisato Kawakami